RavenQuest BioMed
(OTC) RVVQF
RavenQuest BioMed Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.52M
Net Income (TTM)
$32.35M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-15.65 (Low)
Dividend
$0.00
Beta (Volatility)
-15.65 (Low)
Price
$0.00
Volume
106
Open
$0.00
Price
$0.00
Volume
106
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-15.65 (Low)
Price
$0.00
Volume
106
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
RVVQF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RavenQuest BioMed
RVVQF Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
-14%
Net Income Margin
-24%
Return on Equity
0%
Return on Capital
-48%
Return on Assets
-81%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
106
Avg. Volume
159.667
Financials (TTM)
Gross Profit
$801.29K
Operating Income
$17.18M
EBITDA
$27.26M
Operating Cash Flow
$11.10M
Capital Expenditure
$12.26M
Free Cash Flow
$23.36M
Cash & ST Invst.
$362.81K
Total Debt
$13.26M
RavenQuest BioMed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$709.64K
+312.9%
Gross Profit
$442.82K
+182.1%
Gross Margin
62.40%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$3.12M
+1.9%
EBITDA
$1.42M
+41.8%
Quarterly Fundamentals
Net Cash
$14.03M
-25.6%
Accounts Receivable
$915.30K
-40.2%
Inventory
$271.25K
N/A
Long Term Debt
$13.32M
+6.3%
Short Term Debt
$1.46M
N/A
Return on Assets
-80.81%
N/A
Return on Invested Capital
-48.18%
N/A
Free Cash Flow
$2.09M
+82.1%
Operating Cash Flow
$1.44M
+77.0%